Clinical trial
Influence of Trimethoprim-sulfamethoxazole for the Recurrence of Retinochoroiditis Toxoplasma Gondii
NCT01449877 is registered in ClinicalTrials.gov with University of Campinas, Brazil as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Influence of Trimethoprim-sulfamethoxazole for the Recurrence of Retinochoroiditis Toxoplasma Gondii
- Lead sponsor
- University of Campinas, Brazil
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2011
- Completion date
- November 30, 2013
- Enrollment
- 141 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ocular toxoplasmosis